Allworth Financial LP raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 77,045 shares of the healthcare conglomerate's stock after buying an additional 4,007 shares during the quarter. Allworth Financial LP's holdings in UnitedHealth Group were worth $40,352,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Financial Management Professionals Inc. boosted its stake in shares of UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares during the last quarter. Richwood Investment Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after acquiring an additional 20 shares during the last quarter. Global Wealth Strategies & Associates increased its holdings in shares of UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after acquiring an additional 20 shares during the last quarter. Kolinsky Wealth Management LLC lifted its position in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after acquiring an additional 21 shares during the last quarter. Finally, Retirement Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after buying an additional 21 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
UNH has been the subject of a number of recent analyst reports. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Piper Sandler reduced their price objective on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research report on Tuesday, June 3rd. Robert W. Baird downgraded shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target for the company. in a research note on Wednesday, June 11th. Barclays reduced their target price on UnitedHealth Group from $350.00 to $337.00 and set an "overweight" rating on the stock in a report on Wednesday. Finally, TD Securities restated a "hold" rating and set a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $415.00.
View Our Latest Analysis on UNH
Insider Buying and Selling
In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director directly owned 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director owned 3,818 shares of the company's stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.28% of the stock is owned by insiders.
UnitedHealth Group Trading Up 0.6%
Shares of UNH stock traded up $1.91 during trading hours on Friday, reaching $301.42. The company's stock had a trading volume of 5,787,602 shares, compared to its average volume of 7,655,490. The stock has a market capitalization of $273.43 billion, a P/E ratio of 12.61, a P/E/G ratio of 1.45 and a beta of 0.45. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm's fifty day simple moving average is $316.42 and its 200 day simple moving average is $442.28. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the business posted $6.91 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. UnitedHealth Group's payout ratio is presently 37.02%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report